ロード中...
Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQ
Pneumonia infection is a significant cause of morbidity and mortality worldwide. In addition to the public health concerns, pneumonia also accounts for a significant cost to the health care system. Currently there are two leading vaccines targeted against S. pneumoniae: 23-valent pneumococcal polysa...
保存先:
| 出版年: | J Patient Cent Res Rev |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4927079/ https://ncbi.nlm.nih.gov/pubmed/27376105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17294/2330-0698.1214 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|